Chonnam Med J.  2015 Aug;51(2):86-90. 10.4068/cmj.2015.51.2.86.

Prevalence of Smoking and Its Impact on Treatment Outcomes in Newly Diagnosed Pulmonary Tuberculosis Patients: A Hospital-Based Prospective Study

• Mahishale
• Patil B
• Lolly M
• Eti A
• Khan S

• KMID: 2172136
• DOI: http://doi.org/10.4068/cmj.2015.51.2.86

Abstract

There is growing evidence that tobacco smoking is an important risk factor for tuberculosis (TB). India, with a population of 1.26 billion, has the highest number of both TB patients and smokers. The convergence of these two important health hazards is likely severely affecting India's TB control programs. This study was carried out to determine the prevalence of smoking in newly diagnosed pulmonary TB patients and the impact of smoking on disease outcomes in a tertiary care hospital. All patients newly diagnosed with pulmonary TB as per the Revised National Tuberculosis Program of India (RNTCP) 2013 criteria were enrolled in the study. On the basis of their self-reported smoking status, the participants were classified as never smokers, current smokers, and ex-smokers. Patients were started on anti-TB treatment and were followed for 2 years. Among the 2350 subjects (1,758 males and 592 females), 1,593 patients (67.78%) were never smokers. Current and ex-smokers numbered 757 (32.21%), of which 751 (31.95%) were males and 6 (0.26%) were females. Smoking was associated with more extensive lung disease, lung cavitation, and positive sputum smear and culture results at baseline. In both current smokers and ex-smokers, sputum smears and cultures were significantly more likely to remain positive after 2 months of treatment. Ex-smokers and current smokers had significantly high rates of defaults, treatment failures, and relapses. The prevalence of smoking is very high in TB patients. Tobacco smoking is associated with a considerably increased risk of advanced and more severe disease in the form of lung cavitations, positive sputum smear and culture results, and slower smear and culture conversion after initiation of treatment. Smoking has a great negative effect on treatment completion, cure rates, and relapse rates in patients with pulmonary TB.

Keyword

Smoking; Tuberculosis; Recurrence

MeSH Terms

Female
Humans
India
Lung
Lung Diseases
Male
Prevalence*
Prospective Studies*
Recurrence
Risk Factors
Smoke*
Smoking*
Sputum
Tertiary Healthcare
Treatment Failure
Tuberculosis
Tuberculosis, Pulmonary*
Smoke

Reference

1. World Health Organization. Global Tuberculosis report 2014. Geneva, Switzerland: WHO;2014.

2. Esson KM. The Millennium development goals and tobacco control: an opportunity for global partnership. Geneva, Switzerland: World Health Organization;2004.

3. Siddiqi K, Lee AC. An integrated approach to treat tobacco addiction in countries with high tuberculosis incidence. Trop Med Int Health. 2009; 14:420–428.

4. Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med. 2007; 4:e20.

5. Jha P, Jacob B, Gajalakshmi V, Gupta PC, Dhingra N, Kumar R, et al. RGI-CGHR Investigators. A nationally representative casecontrol study of smoking and death in India. N Engl J Med. 2008; 358:1137–1147.

6. John RM, Sung HY, Max W. Economic cost of tobacco use in India, 2004. Tob Control. 2009; 18:138–143.

7. Registrar General of India. Special fertility and mortality survey, 1998: A report of 1.1 million households. New Delhi, India: Registrar General of India;2005.

8. Rani M, Bonu S, Jha P, Nguyen SN, Jamjoum L. Tobacco use in India: prevalence and predictors of smoking and chewing in a national cross sectional household survey. Tob Control. 2003; 12:e4.

9. Wang J, Shen H. Review of cigarette smoking and tuberculosis in China: intervention is needed for smoking cessation among tuberculosis patients. BMC Public Health. 2009; 9:292.

10. Ministry of Health and Population (MOHP) [Nepal]. New ERA, ICF International Inc. Nepal Demographic and Health Survey 2011. Kathmandu, Nepal: Calverton, Maryland: Ministry of Health and Population;New ERA and ICF International;2012.

11. Bhandari R, Sharma R. Epidemiology of chronic obstructive pulmonary disease: a descriptive study in the mid-western region of Nepal. Int J Chron Obstruct Pulmon Dis. 2012; 7:253–257.

12. Leung CC, Yew WW, Chan CK, Tam CM, Lam CW, Chang KC, et al. Smoking and tuberculosis in Hong Kong. Int J Tuberc Lung Dis. 2003; 7:980–986.

13. Altet-Gômez MN, Alcaide J, Godoy P, Romero MA, Hernández del Rey I. Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13,038 cases. Int J Tuberc Lung Dis. 2005; 9:430–436.

14. Wang JY, Hsueh PR, Jan IS, Lee LN, Liaw YS, Yang PC, et al. The effect of smoking on tuberculosis: different patterns and poorer outcomes. Int J Tuberc Lung Dis. 2007; 11:143–149.

15. Maciel EL, Brioschi AP, Peres RL, Guidoni LM, Ribeiro FK, Hadad DJ, et al. Smoking and 2-month culture conversion during anti-tuberculosis treatment. Int J Tuberc Lung Dis. 2013; 17:225–228.

16. Chiang YC, Lin YM, Lee JA, Lee CN, Chen HY. Tobacco consumption is a reversible risk factor associated with reduced successful treatment outcomes of anti-tuberculosis therapy. Int J Infect Dis. 2012; 16:e130–e135.

17. Tachfouti N, Nejjari C, Benjelloun MC, Berraho M, Elfakir S, El Rhazi K, et al. Association between smoking status, other factors and tuberculosis treatment failure in Morocco. Int J Tuberc Lung Dis. 2011; 15:838–843.

18. Chang KC, Leung CC, Tam CM. Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong. Int J Tuberc Lung Dis. 2004; 8:1492–1498.

19. Kittikraisak W, Burapat C, Kaewsa-ard S, Watthanaamornkiet W, Sirinak C, Sattayawuthipong W, et al. Factors associated with tuberculosis treatment default among HIV-infected tuberculosis patients in Thailand. Trans R Soc Trop Med Hyg. 2009; 103:59–66.

20. World Health Organization. Global Tuberculosis report 2013. Geneva, Switzerland: WHO;2013.

21. World Health Organization. A WHO/The Union monograph on TB and tobacco control: joining efforts to control two related global epidemics. Geneva, Switzerland: WHO;2007.